Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study
- To identify and develop highly sensitive and specific tumor markers for the detection
and management of ovarian cancer and other gynecological malignancies.
- To identify new prevention approaches and therapies.
- To identify measures to improve the quality of life for women at increased risk for
developing the disease and for women diagnosed with ovarian cancer.
OUTLINE: Subjects undergo periodic specimen and data collection for research studies,
including molecular, biochemical, functional, and genetic marker studies. Participants may
have samples of blood, tissue, or body fluids (such as ascites, pleural fluid or urine), or
any combination of the aforementioned samples obtained to develop tumor markers to detect
early stage or recurrent ovarian cancer.
The results from the biomarker research studies will not be reported to the patient or the
physician. In the future, if any of the experimental tumor markers are found to be effective
in detecting early stage ovarian cancer, and the patient's result is abnormal, the patient
and physician will be notified.
Subjects may be asked to complete a combination of questionnaires designed to evaluate
psychological functioning among women enrolled in a comprehensive ovarian cancer early
detection program who are at increased risk for developing disease as compared to women
currently diagnosed with ovarian cancer.
Time Perspective: Prospective
Identification and development of highly sensitive and specific tumor markers for the detection and management of ovarian cancer and other gynecological malignancies
Outcomes will be assessed at the completion of the study.
Lee P. Shulman, MD
Robert H. Lurie Cancer Center
United States: Institutional Review Board
|Robert H. Lurie Comprehensive Cancer Center at Northwestern University||Chicago, Illinois 60611|